Financhill
Back

Entrada Therapeutics Stock Predictions

Entrada Therapeutics Stock Forecast

  • Over the next 52 weeks, Entrada Therapeutics has on average historically fallen by 15.7% based on the past 3 years of stock performance.
  • Entrada Therapeutics has fallen lower in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
  • Is Entrada Therapeutics Stock Undervalued?
    The current Entrada Therapeutics [TRDA] share price is $18.80. The Score for TRDA is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
  • TRDA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Entrada Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Entrada Therapeutics has on average historically fallen by 15.7% based on the past 3 years of stock performance.

Entrada Therapeutics Stock Rating

Buy
65
Entrada Therapeutics (TRDA) is a Buy

Is Entrada Therapeutics overpriced?

  • Entrada Therapeutics has fallen lower in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

Entrada Therapeutics Stock Price History

Is TRDA stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TRDA is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
entradatx.com

52-Week Data

52-Week High:
20.49
52-Week Low:
10.95

Prediction Charts

Market Cap:
703.5M
Price in USD:
18.80
Volume:
95.86K
Beta:
-0.26

Technical Analysis

SMA50:
17.01
SMA100:
16.51
SMA200:
15.21
52-Wk Change:
65.49%

Stock Predictions

  • Is Entrada Therapeutics stock public?
    Yes, Entrada Therapeutics is a publicly traded company.
  • What is the Entrada Therapeutics stock quote today?
    The Entrada Therapeutics stock price is 18.80 USD today.
  • How to buy Entrada Therapeutics stock online?
    You can buy Entrada Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-5 18.05 18.62 18.62 17.25
Nov-6 19.75 18.65 19.78 18.15
Nov-7 18.64 19.23 19.85 18.64
Nov-8 19.26 19.82 19.95 18.92
Nov-11 19.91 19.87 20.21 19.58
Nov-12 19.67 19.79 19.88 19.28
Nov-13 19.88 19.98 20.49 19.64
Nov-14 19.88 19.04 20.25 18.95
Nov-15 19.23 17.85 19.23 17.71
Nov-18 17.84 17.45 18.18 17.40
Nov-19 17.30 17.77 17.83 17.09
Nov-20 17.72 17.93 17.94 17.52
Nov-21 17.85 18.05 18.40 17.60
Nov-22 18.12 18.80 18.95 17.90

Entrada Therapeutics Earnings

Entrada Therapeutics Earnings Report: Per Share Entrada Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Entrada Therapeutics Forecast Revenue Growth

Entrada Therapeutics Stock Analysis: Historical quarterly revenues per share for Entrada Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.09 per share, and a decrease next year of $4.11 per share.

* Entrada Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.